Clinical Trial Update: Influence of Glycaemic Balance on the Ability of Apolipoprotein C1 to Inhibit Cholesteryl Ester Transfer Protein in Type-1 Diabetes Patients [NA]

View source ↗

Summary

A clinical trial update indicates the study evaluating how glycemic balance affects Apolipoprotein C1’s inhibition of CETP in Type 1 diabetes patients has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Apolipoprotein C1 (apolipoprotein C1)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: diabète de Type 1 | NA | Status: COMPLETED